Several studies found an association between PLOD2 overexpression and poor outcome in multiple types of cancer, such as sarcoma [32], breast cancer [16], hepatocellular carcinoma [14] and bladder cancer [13]. The gene discussed is PLOD2; the disease is urinary bladder carcinoma.